All-trans-retinoic acid (ATRA): Pediatric acute promyelocytic leukemia

Pediatric Hematology and Oncology

Volumn 15, Issue 3, 1998, Pages 243-248

  Bapna, Ajay ^a   Nair, Reena ^a   Tapan, K Saikia ^a   Nair, C N ^a   Kadam, P ^a   Gladstone, B ^a   Advani, S H ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Hyperleucocytosis; Myeloid leukemia; Pediatric acute promyelocytic leukemia; Retinoic acid syndrome

Indexed keywords

RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHILD; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031866126     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019809028791     Document Type: Article

References (20)

1. Bennette JM, Catovsky D. Daniel MT, et al. Proposed revised criteria for the classification of acyte myeloid leukemia. A report of the French-American-British co-operative group. Ann Intern Med. 1985;103:620-625.
2. Huang M, Yu Chen Y, Shu Rong L, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72:567.
3. Degos L, Chomienne C, Daniel MT, et al. Treatment of first relapse in acute promyelocytic leukemia with all-trans retinoic acid. Lancet. 1990;336:1440.
4. Warrel RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N Engl J Med. 1991;324:1385-1393.
5. de The H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature. 1990;347:558-561.
6. Borrow J, Goddard AD, Sheer D, Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990;249:1557.
7. Alcalay M, Zangrilli D, Pandolfi PP, et al. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus. Proc Natl Acaid Sci USA. 1991;88:1977-1981.
8. Biondi A, Rovelli A, Canto-Rajnoldi A, et al. Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). Leukemia. 1994;8:1264-1268.
9. Stone RM, Mayer RJ. The unique aspect of acute promyelocytic leukemia J Clin Oncol. 1990;8:1913-1921.
10. Cunningham I, Gee TS, Reich LM, Kempin SJ, Naval AN, Clarkson BD. Acute promyelocytic leukemia. Treatment result during a decade at Memorial Hospital. Blood, 1989;73:1116-1122.
11. Marty M, Ganem G, Fischer J, et al. Acute promyelocytic leukemia. Retrospective study of 119 patients treated with daunorubicin. Nouv Rev Fr Hematol. 1978;26:371-378.
12. Kantarjian HM, Keating MJ, Wallers RS, et al. Acute promyelocytic leukemia: the M D Anderson Hospital Experience. Am J Med. 1986;80:789-797.
13. Cordonnier C, Vernant JP, Brun B, et al. Acute promyelocytic leukemia in 57 previously untreated patients. Cancer. 1985;55:18-24.
14. Chen ZX, Xue YQ, Zhang R, et al. A clinical and experimental study on all-trans retinoic acid treated acute promyelocytic leukemia patients. Blood. 1991;78:1413-1419.
15. Fenaux P, Castaigne S, Dombert H, et al. All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remission in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood. 1992;80:2176.
16. Fenaux P, Robert MC, Castaigne S, et al. A multicenter trial comparing all trans retinoic acid plus chemotherapy (ATRA + CT) and CT alone in newly diagnosed acute promyelocytic leukemia (APL). Proc Am Soc Clin Oncol. 1993;12:300. Abstract.
17. Castaigne S, Chomienne C, Daniel MT, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiating therapy for acute promyelocytic leukemia. I. Clinical Result. Blood. 1990;70:1704.
18. Vadhat L, Maslak P, Millre WH, et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leucocytosis, low dose chemotherapy, PML/RARA isoform and CD 13 expression in patients treated with all-trans retinoic acid. Blood. 1994;84:3843-3849.
19. Stanley R, Frankel R, Anna E, et al. Retinoic acid syndrome in acute promyelocytic leukemia. Ann Intern Med. 1994;120:2178-2186.
20. Mashmoud H, Hurwitz C, Roberts W, Santana V, Riberio R, Krance R. Treatment toxicities in children with acute promyelotic leukemia. Lancet. 1993;342:1394-1395.